Bio-Techne(DE:TE1)
€65.62+0.32 (+0.49%)
DE:TE1
Bio-Techne financials statements
€65.62
At close:+0.32 (+0.49%)
Bio-Techne (TE1) Ratios
1 Followers
Bio-Techne Ratios
DE:TE1's free cash flow for Q1 2027 was $67.20M. For the 2027 fiscal year, DE:TE1's free cash flow was decreased by $-5.92M and operating cash flow was $73.11M. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.55 | 3.46 | 3.87 | 4.84 | 3.44 |
| Quick Ratio | 3.35 | 2.38 | 2.75 | 3.50 | 2.64 |
| Cash Ratio | 1.62 | 0.92 | 0.95 | 1.41 | 0.98 |
| Solvency Ratio | 0.58 | 0.29 | 0.44 | 0.58 | 0.63 |
| Operating Cash Flow Ratio | 1.78 | 1.64 | 1.88 | 1.98 | 1.85 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 26.02 |
| Net Current Asset Value | $ 265.90M | $ -30.76M | $ -17.60M | $ -50.69M | $ 11.76M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.11 | 0.17 | 0.16 | 0.17 | 0.14 |
| Debt-to-Equity Ratio | 0.14 | 0.23 | 0.20 | 0.23 | 0.19 |
| Debt-to-Capital Ratio | 0.12 | 0.19 | 0.17 | 0.19 | 0.16 |
| Long-Term Debt-to-Capital Ratio | 0.09 | 0.15 | 0.13 | 0.15 | 0.13 |
| Financial Leverage Ratio | 1.23 | 1.33 | 1.31 | 1.34 | 1.35 |
| Debt Service Coverage Ratio | 52.66 | 22.54 | 18.78 | 36.01 | 15.77 |
| Interest Coverage Ratio | 46.60 | 12.02 | 13.13 | 26.66 | 26.23 |
| Debt to Market Cap | 0.02 | 0.04 | 0.03 | 0.03 | 0.02 |
| Interest Debt Per Share | 1.89 | 2.87 | 2.76 | 2.97 | 2.15 |
| Net Debt to EBITDA | 0.07 | 1.30 | 0.86 | 0.60 | 0.37 |
| Profitability Margins | |||||
| Gross Profit Margin | 65.77% | 64.80% | 66.41% | 67.72% | 68.42% |
| EBIT Margin | 20.25% | 8.77% | 17.38% | 30.78% | 28.28% |
| EBITDA Margin | 28.27% | 17.78% | 27.02% | 40.21% | 37.42% |
| Operating Profit Margin | 20.73% | 8.38% | 17.83% | 26.30% | 26.83% |
| Pretax Profit Margin | 19.81% | 8.07% | 16.02% | 29.79% | 27.26% |
| Net Profit Margin | 14.97% | 6.02% | 14.50% | 25.10% | 24.61% |
| Continuous Operations Profit Margin | 14.97% | 6.02% | 14.50% | 25.11% | 23.80% |
| Net Income Per EBT | 75.56% | 74.55% | 90.53% | 84.23% | 90.27% |
| EBT Per EBIT | 95.55% | 96.29% | 89.84% | 113.29% | 101.62% |
| Return on Assets (ROA) | 7.03% | 2.87% | 6.22% | 10.81% | 11.86% |
| Return on Equity (ROE) | 8.63% | 3.83% | 8.13% | 14.51% | 15.99% |
| Return on Capital Employed (ROCE) | 10.40% | 4.29% | 8.12% | 11.91% | 14.00% |
| Return on Invested Capital (ROIC) | 7.81% | 3.18% | 7.32% | 9.99% | 12.08% |
| Return on Tangible Assets | 13.90% | 6.06% | 13.73% | 23.17% | 28.91% |
| Earnings Yield | 1.65% | 0.91% | 1.49% | 2.22% | 2.00% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.61 | 5.90 | 4.80 | 5.20 | 5.68 |
| Payables Turnover | 15.58 | 16.96 | 10.25 | 14.29 | 10.31 |
| Inventory Turnover | 2.13 | 2.27 | 2.17 | 2.14 | 2.47 |
| Fixed Asset Turnover | 4.06 | 3.82 | 3.38 | 3.50 | 3.83 |
| Asset Turnover | 0.47 | 0.48 | 0.43 | 0.43 | 0.48 |
| Working Capital Turnover Ratio | 2.40 | 2.74 | 2.44 | 2.46 | 2.81 |
| Cash Conversion Cycle | 213.39 | 201.44 | 208.92 | 215.36 | 176.37 |
| Days of Sales Outstanding | 65.06 | 61.91 | 76.02 | 70.15 | 64.23 |
| Days of Inventory Outstanding | 171.76 | 161.05 | 168.50 | 170.76 | 147.55 |
| Days of Payables Outstanding | 23.43 | 21.52 | 35.59 | 25.55 | 35.41 |
| Operating Cycle | 236.82 | 222.96 | 244.51 | 240.91 | 211.78 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.87 | 1.83 | 1.90 | 1.62 | 2.07 |
| Free Cash Flow Per Share | 1.69 | 1.63 | 1.50 | 1.38 | 1.79 |
| Dividend Paid and CapEx Coverage Ratio | 3.71 | 3.53 | 2.64 | 2.87 | 3.42 |
| Capital Expenditure Coverage Ratio | 10.12 | 9.27 | 4.76 | 6.65 | 7.24 |
| Operating Cash Flow Coverage Ratio | 1.01 | 0.65 | 0.71 | 0.56 | 1.00 |
| Operating Cash Flow to Sales Ratio | 0.24 | 0.24 | 0.26 | 0.22 | 0.29 |
| Free Cash Flow Yield | 2.39% | 3.17% | 2.09% | 1.68% | 2.06% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 60.38 | 109.47 | 67.18 | 44.98 | 49.97 |
| Price-to-Sales (P/S) Ratio | 9.07 | 6.64 | 9.74 | 11.29 | 12.30 |
| Price-to-Book (P/B) Ratio | 5.23 | 4.22 | 5.46 | 6.52 | 7.99 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 41.86 | 31.59 | 47.83 | 59.36 | 48.49 |
| Price-to-Operating Cash Flow Ratio | 37.73 | 28.18 | 37.77 | 50.44 | 41.80 |
| Price-to-Earnings Growth (PEG) Ratio | 0.41 | -1.95 | -1.64 | 9.73 | 0.55 |
| Enterprise Value Multiple | 32.15 | 38.67 | 36.92 | 28.67 | 33.23 |
| Enterprise Value | 11.04B | 8.39B | 11.56B | 13.10B | 13.75B |
| EV to EBITDA | 32.15 | 38.67 | 36.92 | 28.67 | 33.23 |
| EV to Sales | 9.09 | 6.88 | 9.97 | 11.53 | 12.44 |
| EV to Free Cash Flow | 41.95 | 32.69 | 48.97 | 60.63 | 49.04 |
| EV to Operating Cash Flow | 37.81 | 29.16 | 38.67 | 51.51 | 42.27 |
| Tangible Book Value Per Share | 5.32 | 3.63 | 3.74 | 3.56 | 2.21 |
| Shareholders’ Equity Per Share | 13.52 | 12.18 | 13.12 | 12.51 | 10.85 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.24 | 0.25 | 0.09 | 0.16 | 0.13 |
| Revenue Per Share | 7.79 | 7.74 | 7.35 | 7.23 | 7.05 |
| Net Income Per Share | 1.17 | 0.47 | 1.07 | 1.81 | 1.73 |
| Tax Burden | 0.76 | 0.75 | 0.91 | 0.84 | 0.90 |
| Interest Burden | 0.98 | 0.92 | 0.92 | 0.97 | 0.96 |
| Research & Development to Revenue | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 |
| SG&A to Revenue | 0.37 | 0.34 | 0.34 | 0.31 | 0.31 |
| Stock-Based Compensation to Revenue | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 |
| Income Quality | 1.61 | 3.92 | 1.78 | 0.89 | 1.24 |
Currency in USD
